Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(11)
- IκB/IKK(64)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(139)
- NF-κB(235)
- Interleukin Related(167)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(35)
- CD73(14)
- Complement System(57)
- Galectin(12)
- IFNAR(25)
- NO Synthase(74)
- NOD-like Receptor (NLR)(50)
- STING(104)
- Reactive Oxygen Species(454)
- Apoptosis(780)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(55)
- Adaptive Immunity(209)
- Allergy(124)
- Arthritis(34)
- Autoimmunity(179)
- Gastric Disease(95)
- Immunosuppressants(37)
- Immunotherapeutics(4)
- Innate Immunity(560)
- Pulmonary Diseases(108)
- Reactive Nitrogen Species(50)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
- Cat.No. 产品名称 Information
-
GC39430
Reslizumab
Sch 55700
Reslizumab (Sch 55700) 是靶向人白介素 5 (IL-5) 的人源化单克隆抗体,用于治疗嗜酸性粒细胞性哮喘。Reslizumab 可有效阻断 IL-5 的功能。Reslizumab 抑制 IL-5 依赖性细胞增殖,IC50 值约为 91.1pM。Reslizumab 对人 IL-5 具有高结合亲和力,在 Biacore 表面等离振子共振和动力学排斥分析中,KD 值分别为 109 pM 和 4.3 pM。 -
GC39428
Quinoclamine
灭藻醌
Quinoclamine 是一种萘醌衍生物,是一种 NF-κB 抑制剂。Quinoclamine 具有抗肿瘤活性。 -
GC39415
OR-1896
左西孟旦杂质
OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂,是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K+ 通道,并具有 Ca2+ 致敏作用。OR-1896 可减轻心肌细胞的凋亡,心脏重塑和心肌炎症。 -
GC39388
GW274150 phosphate
GW274150 phosphate 是一种有效的,选择性的,口服活性的 NADPH 依赖型人一氧化氮合成酶 (iNOS) (Kd=40 nM) 和大鼠 iNOS 抑制剂,对人和大鼠 eNOS 和 nNOS 均显示较低效力。GW274150 phosphate 在急性肺损伤炎症模型中发挥保护作用。
-
GC39382
FW1256
FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),并可用于癌症,炎症和心血管疾病的研究。
-
GC39377
EB-3D
EB-3D is a potent and selective inhibitor of choline kinase α (ChoKα) with IC50 of 1 μM for ChoKα1. EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
-
GC39372
Desethyl chloroquine diphosphate
脱乙基氯喹二磷酸盐
Desethyl chloroquine diphosphate 是 Chloroquine 的主要去乙基代谢产物。Chloroquine 是一种自噬和 toll-like receptors (TLRs) 的抑制剂。Desethyl chloroquine diphosphate 具有抗疟原虫活性。 -
GC39365
CPTH2
A HAT inhibitor
-
GC39355
BTSA1
BTSA1 is a pharmacologically optimized BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis. It effectively promotes apoptosis in leukemia cell lines and patient samples while sparing healthy cells.
-
GC39346
Benralizumab
MEDI-563; BIW-8405
Benralizumab (MEDI-563) 是一种白介素 5 受体 α (IL-5Rα) 定向的溶细胞单克隆抗体,通过增强抗体依赖性细胞介导的细胞毒性诱导嗜酸性粒细胞直接,快速和几乎完全耗尽。Benralizumab 可用于严重的嗜酸性哮喘。 -
GC39326
2-Iminobiotin hydrobromide
2-亚氨基生物素盐酸盐; Guanidinobiotin hydrobromide
2-Iminobiotin hydrobromide (Guanidinobiotin hydrobromide) 是一种生物素 (维生素 H 或 B7) 类似物。2-Iminobiotin hydrobromide 是一种可逆的 NO 合酶抑制剂,作用于小鼠 iNOS 和大鼠 n-cNOS,Ki 值分别为 21.8 和 37.5 μM。2-Iminobiotin hydrobromide 与低温环境可保护人类神经细胞免受缺氧诱导的细胞损伤。 -
GC39325
2,5-Dihydroxyacetophenone
2,5-二羟基苯乙酮; 2',5'-二羟基苯乙酮
2',5'-Dihydroxyacetophenone (DHAP, 2-Acetylhydroquinone, Quinacetophenone) is a mixture of dihydroxyacetophenone isomers is used in food flavouring. 2',5'-Dihydroxyacetophenone significantly inhibits NO production via the suppression of iNOS expression. 2',5'-Dihydroxyacetophenone significantly decreases levels of the pro-inflammatory cytokines TNF-α and IL-6 by blocking the ERK1/2 and NF-κB signaling pathways. -
GC39321
(Rac)-Myrislignan
ALPHA-[1-[2,6-二甲氧基-4-(2-丙烯-1-基)苯氧基]乙基]-4-羟
(Rac)-Myrislignan 是Myrislignan 的外消旋体。 Myrislignan 是从Myristica fragrans Houtt 分离得到的一种木酚素,具有抗炎活性。Myrislignan 通过抑制NF-kB信号通路的激活,减轻LPS诱导的小鼠巨噬细胞炎症反应。 -
GC50611
NBC 6
NBC 6 是一种有效的、选择性的 NLRP3 炎性体抑制剂 (IC50= 574 nM),其作用独立于 Ca2+。
-
GC50569
NLRP3-IN-2
4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺
An NLRP3 inflammasome inhibitor -
GC50556
NBC 19
Potent NLRP3 inflammasome inhibitor
-
GC50511
UCLA GP130 2
A humanin peptide mimetic
-
GC50422
10-Cl-BBQ
Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable
-
GC50374
TH 1020
An inhibitor of the TLR5-flagellin protein-protein interaction
-
GC50356
CL 075
2-丙基噻唑并[4,5-C]喹啉-4-胺,3M002
CL 075 (3M002) 是一种具有免疫调节特性的选择性 TLR8 激动剂。 -
GC50350
TC JL 37
TC JL 37 是一种有效的、选择性的、可口服的 TYK2 抑制剂,Ki 为 1.6 nM。
-
GC50342
CP 424174
An inhibitor of stimulus-coupled IL-1β post-translational processing
-
GC50297
RS 09
A TLR4 agonist
-
GC50296
D9
D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。
-
GC50292
c-Di-GMP sodium salt
Endogenous STING and DDX41 agonist; activates STING-dependent signaling
-
GC50280
JX 06
NSC 402538
An irreversible PDHK inhibitor -
GC50253
PF 543 hydrochloride
Sphingosine Kinase 1 Inhibitor II hydrochloride
A potent inhibitor of SPHK1 -
GC50243
NFAT inhibitor, Cell Permeable
A cell-permeable form of NFAT inhibitor
-
GC50242
RA 839
RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。
-
GC50241
M62812
TLR-4 inhibitor
-
GC50238
PMX 53c
Negative control for PMX 53
-
GC50190
Fenretinide - d4
4-HPR-d4, 4-Hydroxy(phenyl)retinamide-d4, Retinoic Acid p-hydroxyphenylamide-d4
An internal standard for the quantification of fenretinide -
GC50176
PMX 53
3D53
PMX 53 (3D53) 是一种合成肽类,是一种有效且具有口服活性的补体 C5a 受体 (CD88) 拮抗剂,IC50 为 20 nM。 -
GC50165
SM 324405
A TLR7 agonist
-
GC50139
SP 100030
SP 100030 是一种有效的 NF-κB 和 activator protein-1 (AP-1) 双抑制剂(IC50s 分别为 50 和 50 nM)。
-
GC50109
AZD 5582 dihydrochloride
A Smac mimetic and IAP inhibitor
-
GC50101
TFC 007
An H-PGDS inhibitor
-
GC50093
MRT 68601 hydrochloride
Potent TBK inhibitor
-
GC50045
PD 166285 dihydrochloride
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐
A tyrosine kinase inhibitor -
GC50011
Nw-Propyl-L-arginine hydrochloride
N-omega-Propyl-L-arginine hydrochloride
Nω-Propyl-L-arginine (N-omega-Propyl-L-arginine) hydrochloride 是一种有效的、竞争性的、高度选择性的神经元一氧化氮合酶 (nNOS) 抑制剂,Ki 为 57 nM。 -
GC50009
LY 294002 hydrochloride
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
-
GC39311
YQ128
An NLRP3 inflammasome inhibitor
-
GC39302
PARP14 inhibitor H10
PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
-
GC39296
1G244
1G244 是一种有效的 DPP8/9 抑制剂,IC50 分别为 12 nM 和 84 nM,但不抑制 DPPIV 和 DPPII。1G244 可诱导多发性骨髓瘤细胞凋亡,并具有抗骨髓瘤作用。
-
GC39295
DJ001
DJ001 是一种高度特异性,选择性和非竞争性的蛋白酪氨酸磷酸酶-σ (PTPσ) 抑制剂,IC50 为 1.43 μM。DJ001 对其他磷酸酶无抑制活性,对蛋白质磷酸酶 5 仅有中等抑制活性。DJ001 促进造血干细胞再生。
-
GC39285
CU-T12-9
An agonist of TLR1/2
-
GC39284
ANI-7
ANI-7 是一种 AhR 途径的激活剂。ANI-7 抑制多种癌细胞的生长,并有选择地抑制 MCF-7 乳腺癌细胞的生长,GI50 为 0.56 μM。ANI-7 通过激活 AhR 途径诱导 CYP1 代谢单加氧酶,并在敏感的乳腺癌细胞系中诱导 DNA 损伤,检查点激酶 (Chk2) 激活,S 期细胞周期停滞和细胞死亡。
-
GC39281
(R)-CR8 trihydrochloride
CR8, (R)-Isomer trihydrochloride
An inhibitor of cyclin-dependent kinases -
GC39280
B022
4-(1-(2-氨基-5-氯嘧啶-4-基)-2-(噻唑-2-基)-3-丁炔-2-醇
B022 是一种有效的选择性的 NF-κB 诱导激酶 (NIK) 抑制剂,Ki 为 4.2 nM。B022 可保护肝脏免受毒素引起的炎症,氧化应激和伤害。 -
GC39271
(±)-Naringenin
(±)-柚皮素
A citrus-derived flavonoid